| 97.73 Data as of May 22 |  -0.81 / -0.82%Today’s Change | 81.28 Today|||52-Week Range 116.45 | +6.54% Year-to-Date |
| 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGN May 20 / TheStreet.com | AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com |
| Allergan Stock To Go Ex-dividend Tomorrow (AGN) May 20 / TheStreet.com |
| Previous close | 98.54 |
| Today’s open | 98.52 |
| Day’s range | 97.46 - 99.33 |
| Volume | 2,799,459 |
| Average volume (3 months) | 1,820,364 |
| Market cap | $29.2B |
| Dividend yield | 0.20% |
| Earnings growth (last year) | +18.94% |
| Earnings growth (this year) | +14.76% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.58% |
| P/E ratio | 26.2 |
| Price/Sales | 4.76 |
| Price/Book | 5.07 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRXValeant Pharmaceutic... | -0.71 | -0.94% |
| ALXNAlexion Pharmaceutic... | -2.10 | -2.05% |
| SHPGShire PLC | +0.10 | +0.10% |
| VRTXVertex Pharmaceutica... | -1.04 | -1.31% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $5.8B |
| Annual profit (last year) | $1.1B |
| Net profit margin | 18.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer David E. I. Pyott, MBA |
Chief Financial Officer & EVP-Business Development Jeffrey L. Edwards |
Corporate headquarters Irvine, California |
.
